Moderna (MRNA) Gross Profit (QoQ) (2020 - 2026)
Moderna (MRNA) Gross Profit (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,015.37 Bn | 1,015.37 Bn | - |
| 4 | BeOne Medicines | 471.39 Bn | 466.59 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.52 Bn | 115.28 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.33 Bn | 61.58 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | Moderna | 22.07 Bn | 16.87 Bn | -566.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -350.44% |
| Dec 31, 2025 | -72.06% |
| Sep 30, 2025 | 3,417.39% |
| Jun 30, 2025 | 27.78% |
| Mar 31, 2025 | -92.07% |
| Dec 31, 2024 | -83.16% |
| Sep 30, 2024 | 969.84% |
| Jun 30, 2024 | 77.46% |
| Mar 31, 2024 | -96.23% |
| Dec 31, 2023 | 559.02% |
| Sep 30, 2023 | -5.94% |
| Jun 30, 2023 | -136.17% |
| Mar 31, 2023 | -77.16% |
| Dec 31, 2022 | 106.89% |
| Sep 30, 2022 | -32.78% |
| Jun 30, 2022 | -33.29% |
| Mar 31, 2022 | -19.33% |
| Dec 31, 2021 | 47.37% |
| Sep 30, 2021 | 17.84% |
| Jun 30, 2021 | 106.65% |